3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
NETWORK
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Breast Neoplasms
69
Carcinoma, Intraductal, Noninfiltrating
9
Breast Carcinoma In Situ
6
Breast Neoplasms, Male
5
Neoplasms
3
Neoplasm Metastasis
3
Urinary Bladder Neoplasms
2
Inflammatory Breast Neoplasms
2
Sleep Wake Disorders
1
Risk Reduction Behavior
1
Prostatic Neoplasms
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Obesity
1
Newly Diagnosed Hormone Positive Clinical Stage 1 or 2 Breast Cancer
1
Mastodynia
1
Glioma
1
Fibrocystic Breast Disease
1
Fibroadenoma
1
Fatigue
1
Fallopian Tube Neoplasms
1
Endometrial Neoplasms
1
Disease Progression
1
Desmoid Tumors
1
Cystic Fibrosis
1
Cystadenocarcinoma, Serous
1
Carcinoma, Ovarian Epithelial
1
Carcinoma, Lobular
1
Bulbo-Spinal Atrophy, X-Linked
1
Breast Cancer Metastatic
1
Interventions
Modafinil
14
Surveys and Questionnaires
6
Methylphenidate
6
Yoga
4
Educational Status
3
Ultraviolet Therapy
2
Therapeutics
2
Sugars
2
Palliative Care
2
Donepezil
2
Dexamethasone
2
Calcium Dobesilate
2
Asian ginseng
2
Acceptance and Commitment Therapy
2
testosterone enanthate
1
testosterone 17 beta-cypionate
1
regorafenib
1
ofatumumab
1
exemestane
1
eicosapentaenoic acid ethyl ester
1
eicosapentaenoic acid ethanolamide
1
dexamethasone acetate
1
dexamethasone 21-phosphate
1
coenzyme Q10
1
caffeine, sodium benzoate drug combination
1
auricularum
1
Vitamin E
1
Triptorelin Pamoate
1
Transcranial Magnetic Stimulation
1
Transcranial Direct Current Stimulation
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Has results
×
Fatigue
×
Tamoxifen
×
Clear all
NCT00659373
2016-07-25
Co-SOFT
ETOP IBCSG Partners Foundation
Phase 3
Completed
86 enrolled
4 charts